세계의 면역진단 시장 규모 조사 및 예측 : 제품별, 용도별, 최종사용자별, 지역별 분석(2023-2030년)

Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics is a branch of diagnostics that utilizes the immune system's response to detect diseases or infections. It involves the use of various techniques to measure specific components of the immune system, such as antibodies, antigens, or cytokines, in order to diagnose diseases accurately. The immunodiagnostics has revolutionized the field of diagnostics by providing accurate, sensitive, and rapid methods for disease detection and monitoring across a wide range of medical conditions. Moreover, the rising prevalence of infectious diseases, growing geriatric population, increasing awareness and demand for personalized medicine are anticipated to create the lucrative demand for the market during forecast period 2023-2030.

Additionally, growing awareness among patients and healthcare professionals about the benefits of personalized medicine, which relies on precise diagnostic tests to tailor treatments according to individual patient characteristics. Immunodiagnostics plays a crucial role in facilitating personalized medicine approaches. Thus, the growing demand for the personalized medicines is anticipated to support the market growth. According to Statista, in 2019, the personalized medicine market was valued USD 1980 billion and it is anticipated to reach USD 2770 billion in 2022. Moreover, the rising healthcare expenditure, and supportive government initiatives and funding are anticipated to create the lucrative opportunity for the market growth. However, the high cost of immunodiagnostic products and stringent government regulations stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Immunodiagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the increasing healthcare expenditure, continuous advancement in immunodiagnostic technologies, presence of key market players, and rising awareness and focus on preventive healthcare. Whereas, the Asia Pacific region is expected to grow with the fastest growth rate during the forecast period, owing to factors such as the rising incidence of chronic diseases such as cancer, diabetes, autoimmune disorders, and infectious diseases like HIV/AIDS, growing aging population, supportive regulatory environment, presence of leading pharmaceutical and biotechnology companies, academic research institutions, and government initiatives supporting research and development activities in immunodiagnostics.

Major market players included in this report are:

• Sysmex Corporation
• Arkray, Inc.
• Danaher Corporation (Beckman Coulter)
• Siemens AG
• Immunodiagnostic Systems Holdings Plc
• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Diasorin S.P.A.
• Johnson & Johnson Services, Inc.

Recent Developments in the Market:

• In August 2022, Bio-Rad Laboratories acquired the shares of Curiosity Diagnostics. Curiosity Diagnostics is a Warsaw, Poland-based developer of innovative technology solutions catering to several markets of healthcare and medical diagnostics.

Global Immunodiagnostics Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Application, End user, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Instruments
• Reagents & Consumables

By Application:

• Oncology & Endocrinology
• Hepatitis & Retrovirus
• Cardiac Markers
• Infectious Diseases
• Others

By End user:

• Clinical Laboratories
• Hospitals
• Physician's Offices
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Immunodiagnostics Market, by region, 2020-2030 (USD Billion)
  • 1.2.2.Immunodiagnostics Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3.Immunodiagnostics Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Immunodiagnostics Market, by End user, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Immunodiagnostics Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Immunodiagnostics Market Dynamics

• 3.1.Immunodiagnostics Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Rising prevalence of infectious diseases
    • 3.1.1.2.Growing geriatric population
    • 3.1.1.3.Increasing awareness and demand for personalized medicine
  • 3.1.2.Market Challenges
    • 3.1.2.1.High cost of immunodiagnostic products
    • 3.1.2.2.Stringent government regulations
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Rising healthcare expenditure
    • 3.1.3.2.Supportive government initiatives and fundings

Chapter 4.Global Immunodiagnostics Market: Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economic
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Immunodiagnostics Market, by Product

• 5.1.Market Snapshot
• 5.2.Global Immunodiagnostics Market by Product, Performance - Potential Analysis
• 5.3.Global Immunodiagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4.Immunodiagnostics Market, Sub Segment Analysis
  • 5.4.1.Instruments
  • 5.4.2.Reagents & Consumables

Chapter 6.Global Immunodiagnostics Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Immunodiagnostics Market by Application, Performance - Potential Analysis
• 6.3.Global Immunodiagnostics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Immunodiagnostics Market, Sub Segment Analysis
  • 6.4.1.Oncology & Endocrinology
  • 6.4.2.Hepatitis & Retrovirus
  • 6.4.3.Cardiac Markers
  • 6.4.4.Infectious Diseases
  • 6.4.5.Others

Chapter 7.Immunodiagnostics Market, by End user

• 7.1.Market Snapshot
• 7.2.Global Immunodiagnostics Market by End user, Performance - Potential Analysis
• 7.3.Global Immunodiagnostics Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
• 7.4.Immunodiagnostics Market, Sub Segment Analysis
  • 7.4.1.Clinical Laboratories
  • 7.4.2.Hospitals
  • 7.4.3.Physician's Offices
  • 7.4.4.Others

Chapter 8.Global Immunodiagnostics Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Immunodiagnostics Market, Regional Market Snapshot
• 8.4.North America Immunodiagnostics Market
  • 8.4.1.U.S. Immunodiagnostics Market
    • 8.4.1.1.Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End user breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Immunodiagnostics Market
• 8.5.Europe Immunodiagnostics Market Snapshot
  • 8.5.1.U.K. Immunodiagnostics Market
  • 8.5.2.Germany Immunodiagnostics Market
  • 8.5.3.France Immunodiagnostics Market
  • 8.5.4.Spain Immunodiagnostics Market
  • 8.5.5.Italy Immunodiagnostics Market
  • 8.5.6.Rest of Europe Immunodiagnostics Market
• 8.6.Asia-Pacific Immunodiagnostics Market Snapshot
  • 8.6.1.China Immunodiagnostics Market
  • 8.6.2.India Immunodiagnostics Market
  • 8.6.3.Japan Immunodiagnostics Market
  • 8.6.4.Australia Immunodiagnostics Market
  • 8.6.5.South Korea Immunodiagnostics Market
  • 8.6.6.Rest of Asia Pacific Immunodiagnostics Market
• 8.7.Latin America Immunodiagnostics Market Snapshot
  • 8.7.1.Brazil Immunodiagnostics Market
  • 8.7.2.Mexico Immunodiagnostics Market
• 8.8.Middle East & Africa Immunodiagnostics Market
  • 8.8.1.Saudi Arabia Immunodiagnostics Market
  • 8.8.2.South Africa Immunodiagnostics Market
  • 8.8.3.Rest of Middle East & Africa Immunodiagnostics Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.Sysmex Corporation
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Arkray, Inc.
  • 9.3.3.Danaher Corporation (Beckman Coulter)
  • 9.3.4.Siemens AG
  • 9.3.5.Immunodiagnostic Systems Holdings Plc
  • 9.3.6.Thermo Fisher Scientific, Inc.
  • 9.3.7.F. Hoffmann-La Roche Ltd.
  • 9.3.8.Abbott Laboratories
  • 9.3.9.Diasorin S.P.A.
  • 9.3.10.Johnson & Johnson Services, Inc

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption